Search details
1.
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
Cancer
; 130(3): 385-399, 2024 02 01.
Article
in English
| MEDLINE | ID: mdl-37751191
2.
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Gynecol Oncol
; 183: 78-84, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38554477
3.
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
Gynecol Oncol
; 175: 32-40, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37321153
4.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol
; 178: 14-22, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37741201
5.
Pembrolizumab with or without bevacizumab for recurrent or metastatic cervical cancer: A cost-effectiveness analysis.
Gynecol Oncol
; 165(3): 500-505, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35422338
6.
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Gynecol Oncol
; 167(2): 174-180, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36154763
7.
Elevated lipid oxidation is associated with exceeding gestational weight gain recommendations and increased neonatal anthropometrics: a cross-sectional analysis.
BMC Pregnancy Childbirth
; 21(1): 575, 2021 Aug 21.
Article
in English
| MEDLINE | ID: mdl-34419005
8.
Water only fasting and its effect on chemotherapy administration in gynecologic malignancies.
Gynecol Oncol
; 159(3): 799-803, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32958269
9.
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy".
Cancer
; 130(9): 1713-1714, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38430468
10.
Authentic leadership in action: Experience gained from a gynecologic oncology fellowship leadership curriculum.
Gynecol Oncol
; 182: 176-178, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38330810
11.
Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" [Gynecologic Oncology 183 (2024) 78-84].
Gynecol Oncol
; 183: R1, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38839145
12.
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University.
Gynecol Oncol Rep
; 52: 101327, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38390623
13.
Gauging the Acceptance of Telemedicine in Postoperative Evaluation of Uncomplicated Laparoscopic Appendectomy and Cholecystectomy.
Telemed Rep
; 4(1): 259-265, 2023.
Article
in English
| MEDLINE | ID: mdl-37637377
14.
Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer.
Front Oncol
; 13: 1147657, 2023.
Article
in English
| MEDLINE | ID: mdl-37091179
15.
Reporting Subclonal Immunohistochemical Staining of Mismatch Repair Proteins in Endometrial Carcinoma in the Times of Ever-Changing Guidelines.
Arch Pathol Lab Med
; 146(9): 1114-1121, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-34979565
16.
Optimizing contraceptive access for women undergoing bariatric surgery.
Surg Obes Relat Dis
; 16(12): 2082-2087, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33004300
Results
1 -
16
de 16
1
Next >
>>